Frontierby eninvs

Language: EN · RU

← Region

AMGEN INC (AMGN) USD

At a glance: strengths & risks
✓Revenue growing (+10%)✓Profit growing (+89%)✗High leverage (3.3x EBITDA)

Sector: Health care

US_AMGN

Price chart

371.5 USDDay 1.49%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
371.5 USD · 1.49%
Market cap
200.2 bn USD

Growth

Δ revenue y/y
5.8%
Δ EBITDA y/y
47.4%

Multiples

P/E (LTM)
25.7x
3y avg: 29.9x
P/B (FY)
23.1x
P/E (ann.)
27.5x
EV/EBITDA (LTM)
15.9x
3y avg: 17.2x
EV/EBITDA (ann.)
16.2x

Cash return

Dividend yield
2.6%
FCF yield (LTM)
4.2%

Value creation

fundamental value/yr, % of market cap
Value created / year
+37.8%
↓ details

Liquidity

Daily turnover (US listing)
921.1 mln USD

Shares: yahoo_fundamentals_timeseries/AMGN

Financial results

Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB USDOperating profitB USDD&AB USDEBITDAB USDNet profitB USDOperating CFB USDCapex + M&AB USDAssetsB USDEquityB USDROE (annualized)Net debtB USDSource
2026-03-31Q1 2026 (3M)OK8.6
y/y 5.8%
2.7
y/y 126.3%
1.1
y/y -19.5%
3.8
y/y 47.4%
1.8
y/y 5.1%
2.2-0.792.5
y/y 3.5%
9.2
y/y 48.1%
81.5%45.3Link
2025-12-31Q4 2025 (3M)OK9.9
y/y 8.6%
2.7
y/y 17.7%
1.1
y/y -19.0%
3.9
y/y 3.9%
1.3
y/y 112.6%
1.6-0.790.6
y/y -1.4%
8.7
y/y 47.3%
84.4%46.3Link
2025-09-30Q3 2025 (3M)OK9.6
y/y 12.4%
2.5
y/y 23.4%
1.3
y/y -6.4%
3.8
y/y 11.3%
3.2
y/y 13.6%
4.7-0.490.1
y/y -0.8%
9.6
y/y 27.8%
50.3%45.1Link
2025-06-30Q2 2025 (3M)OK9.2
y/y 9.4%
2.7
y/y 39.1%
1.3
y/y -4.2%
4.0
y/y 20.8%
1.4
y/y 92.0%
2.3-0.487.9
y/y -3.3%
7.4
y/y 25.4%
84.0%48.2Link
2025-03-31Q1 2025 (3M)OK8.1
y/y 9.4%
1.2
y/y 18.9%
1.4
y/y -0.9%
2.6
y/y 7.3%
1.7
y/y —
1.4-0.489.4
y/y -3.9%
6.2
y/y 23.6%
114.5%48.6Link
2024-12-31Q4 2024 (3M)OK9.1
y/y 10.9%
2.3
y/y 81.8%
1.4
y/y 1.2%
3.7
y/y 39.9%
0.6
y/y -18.3%
4.8-0.491.8
y/y -5.5%
5.9
y/y -5.7%
61.0%48.9Link
2024-09-30Q3 2024 (3M)OK8.5
y/y 23.2%
2.0
y/y 1.3%
1.4
y/y 56.0%
3.4
y/y 18.1%
2.8
y/y 63.6%
3.6-0.390.9
y/y 0.4%
7.5
y/y -1.7%
56.1%51.4Link
2024-06-30Q2 2024 (3M)OK8.4
y/y 20.1%
1.9
y/y -28.9%
1.4
y/y 56.2%
3.3
y/y -7.6%
0.7
y/y -45.9%
2.5-0.290.9
y/y 0.7%
5.9
y/y -12.6%
54.5%53.3Link
2024-03-31Q1 2024 (3M)OK7.4
y/y 22.0%
1.0
y/y -48.4%
1.4
y/y 55.4%
2.4
y/y -15.3%
-0.1
y/y -104.0%
0.7-0.293.0
y/y 4.8%
5.0
y/y -6.1%
-8.0%54.3Link
2023-12-31Q4 2023 (3M)OK8.2
y/y —
1.3
y/y —
1.4
y/y —
2.7
y/y —
0.8
y/y —
0.5-27.297.2
y/y —
6.2
y/y —
96.7%54.5Link
2023-09-30Q3 2023 (3M)OK6.9
y/y —
2.0
y/y —
0.9
y/y —
2.9
y/y —
1.7
y/y —
2.8-0.290.5
y/y —
7.7
y/y —
32.0%25.7Link
2023-06-30Q2 2023 (3M)OK7.0
y/y —
2.7
y/y —
0.9
y/y —
3.6
y/y —
1.4
y/y —
4.1-0.390.3
y/y —
6.8
y/y —
91.0%27.3Link
2023-03-31Q1 2023 (3M)OK6.1
y/y —
1.9
y/y —
0.9
y/y —
2.8
y/y —
2.8
y/y —
1.1-0.388.7
y/y —
5.3
y/y —
—30.0Link

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

02 0004 0006 0008 00010 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Year-over-year change

-20%0%20%40%2023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Cash flow

FCF ($ mln)

-30 000-20 000-10 00002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Net debt / cash ($ mln)

020 00040 00060 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Fundamental value creation

Value the company creates per year, as a % of market cap

Value created per year: +37.7%

How this was calculated
1. EBITDA growth (latest quarter YoY, annualised)
[EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-03-31 vs 2025-03-31)
= (3 782 − 2 565) × 4.09
4 976
2. Current EV/EBITDA (LTM)
(Market cap + Net debt) ÷ EBITDA (LTM)
= (200 164 + 45 285) ÷ 15 464
15.9x
3. Target multiple
(Current EV/EBITDA + 12) ÷ 2
= (15.9 + 12) ÷ 2
13.9x
4. Cash flow (balance method, LTM)
Net-debt reduction + dividends + buybacks − equity issuance
= 3 286 + 3 920 + 0 − 0
7 206
4b. Share dilution (at market, LTM)
Share-count growth over the year × Market cap
= 0.6% × 200 164
−1 110
5. Value created per year
(EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap
= (4 976 × 13.9 + 7 206 − 1 110) ÷ 200 164
+37.7%

Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.

Caveats:

  • share-count dilution 0.6%/yr (valued at market: -1110)

Revenue growth & acceleration

Growth decelerating ▼
Last-year revenue growth +10% vs +19% the year before — a -8.6 pp move. 3-year CAGR +12%.
revenue growth by year: 2023 +7% · 2024 +19% · 2025 +10%
The growth-acceleration signal behind the GARP+acceleration strategy — it favours companies whose revenue growth is speeding up and flags those slowing down (the second derivative of growth).

EV/EBITDA — daily history

Current 15.6x · 3-year average 17.4x

EV/EBITDA3-year 75th pct

Dividends

Paid (completed)

DatePer shareDetailsStatusSource
2026-05-152.52 USDEx-dividend: 2.52 USD per sharePaidYahoo Finance (ex-div)
2026-02-132.52 USDEx-dividend: 2.52 USD per sharePaidYahoo Finance (ex-div)
2025-11-212.38 USDEx-dividend: 2.38 USD per sharePaidYahoo Finance (ex-div)
2025-08-222.38 USDEx-dividend: 2.38 USD per sharePaidYahoo Finance (ex-div)
2025-05-162.38 USDEx-dividend: 2.38 USD per sharePaidYahoo Finance (ex-div)
2025-02-142.38 USDEx-dividend: 2.38 USD per sharePaidYahoo Finance (ex-div)
2024-11-182.25 USDEx-dividend: 2.25 USD per sharePaidYahoo Finance (ex-div)
2024-08-162.25 USDEx-dividend: 2.25 USD per sharePaidYahoo Finance (ex-div)
2024-05-162.25 USDEx-dividend: 2.25 USD per sharePaidYahoo Finance (ex-div)
2024-02-152.25 USDEx-dividend: 2.25 USD per sharePaidYahoo Finance (ex-div)
2023-11-162.13 USDEx-dividend: 2.13 USD per sharePaidYahoo Finance (ex-div)
2023-08-172.13 USDEx-dividend: 2.13 USD per sharePaidYahoo Finance (ex-div)
2023-05-172.13 USDEx-dividend: 2.13 USD per sharePaidYahoo Finance (ex-div)
2023-02-142.13 USDEx-dividend: 2.13 USD per sharePaidYahoo Finance (ex-div)
2022-11-161.94 USDEx-dividend: 1.94 USD per sharePaidYahoo Finance (ex-div)
2022-08-171.94 USDEx-dividend: 1.94 USD per sharePaidYahoo Finance (ex-div)
2022-05-161.94 USDEx-dividend: 1.94 USD per sharePaidYahoo Finance (ex-div)
2022-02-141.94 USDEx-dividend: 1.94 USD per sharePaidYahoo Finance (ex-div)
2021-11-151.76 USDEx-dividend: 1.76 USD per sharePaidYahoo Finance (ex-div)
2021-08-161.76 USDEx-dividend: 1.76 USD per sharePaidYahoo Finance (ex-div)

KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)

Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of AMGEN INC (AMGN) — from primary filings.

Biotechnology medicines for oncology, inflammation, cardiovascular disease, and bone health.

Frequently asked questions

What is AMGEN INC (AMGN)'s P/E ratio?
AMGEN INC (AMGN) trades at a P/E of 25.7x (price to trailing 12-month earnings).
What is AMGEN INC (AMGN)'s EV/EBITDA?
AMGEN INC (AMGN) trades at 15.9x EV/EBITDA.
What is AMGEN INC (AMGN)'s P/B ratio?
AMGEN INC (AMGN) trades at a P/B of 23.1x.
What is AMGEN INC (AMGN)'s dividend yield?
AMGEN INC (AMGN)'s trailing 12-month dividend yield is 2.6%.
What is AMGEN INC (AMGN)'s return on equity (ROE)?
AMGEN INC (AMGN)'s ROE is 81.5%.
What is AMGEN INC (AMGN)'s market capitalization?
AMGEN INC (AMGN)'s market cap is 200.2 bn USD.